School of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, USA.
Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN 47907, USA.
J Control Release. 2023 May;357:484-497. doi: 10.1016/j.jconrel.2023.04.024. Epub 2023 Apr 21.
Many drugs are poorly water-soluble and suffer from low bioavailability. Metal-phenolic network (MPN), a hydrophilic thin layer such as tannic acid (TA)-Fe network, has been recently used to encapsulate hydrophobic drugs to improve their bioavailability. However, it remains challenging to synthesize nanocapsules of a wide variety of hydrophobic drugs and to scale up the production in a continuous manner. Here, we present a microfluidic synthesis method to continuously produce TA-Fe network nanocapsules of hydrophobic drugs. We hypothesize that nanocapsules can continuously be formed only when the microfluidic mixing timescale is shorter than the drug's nucleation timescale. The hypothesis was tested on three hydrophobic drugs - paclitaxel, curcumin, and vitamin D with varying solubility and nucleation timescale. The proposed mechanism was validated by successfully predicting the synthesis outcomes. The microfluidically-synthesized nanocapsules had well-controlled sizes of 100-200 nm, high drug loadings of 40-70%, and a throughput of up to 70 mg hr per channel. The release kinetics, cellular uptake, and cytotoxicity were further evaluated. The effect of coating constituents on nanocapsule properties were characterized. Fe content of nanocapsules was reported. The stability of nanocapsules at different temperatures and pHs were also tested. The results suggest that the present method can provide a quantitative guideline to predictively design a continuous synthesis scheme for hydrophobic drug encapsulation via MPN nanocapsules with scaled-up capability.
许多药物的水溶性较差,生物利用度低。金属-酚网络(MPN),例如单宁酸(TA)-Fe 网络,是一种亲水的薄层,已被用于包裹疏水性药物以提高其生物利用度。然而,合成各种疏水性药物的纳米胶囊并以连续的方式进行规模化生产仍然具有挑战性。在这里,我们提出了一种微流控合成方法,可连续生产疏水性药物的 TA-Fe 网络纳米胶囊。我们假设,只有当微流混合时间尺度短于药物成核时间尺度时,纳米胶囊才能连续形成。该假设通过对三种疏水性药物 - 紫杉醇、姜黄素和维生素 D - 进行测试得到了验证,这三种药物的溶解度和成核时间尺度不同。所提出的机制通过成功预测合成结果得到了验证。通过微流控合成的纳米胶囊具有良好控制的尺寸为 100-200nm,药物负载率高达 40-70%,每个通道的通量高达 70mg/hr。进一步评估了释放动力学、细胞摄取和细胞毒性。还研究了涂层成分对纳米胶囊性质的影响。报道了纳米胶囊的铁含量。还测试了纳米胶囊在不同温度和 pH 值下的稳定性。结果表明,该方法可以为通过 MPN 纳米胶囊进行的疏水性药物包封提供定量指导,以预测性地设计连续合成方案,具有规模化能力。